|
LOC723972 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.643700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.912300E-02 |
| Normal-vs-Stage2 |
9.567400E-01 |
| Normal-vs-Stage3 |
1.162010E-01 |
| Normal-vs-Stage4 |
7.977300E-03 |
| Stage1-vs-Stage2 |
1.742810E-01 |
| Stage1-vs-Stage3 |
7.839400E-01 |
| Stage1-vs-Stage4 |
1.202840E-01 |
| Stage2-vs-Stage3 |
2.514800E-01 |
| Stage2-vs-Stage4 |
3.248400E-02 |
| Stage3-vs-Stage4 |
1.190210E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.112000E-02 |
| Normal-vs-AfricanAmerican |
8.988600E-04 |
| Normal-vs-Asian |
8.388600E-01 |
| Caucasian-vs-AfricanAmerican |
5.863900E-03 |
| Caucasian-vs-Asian |
2.729000E-01 |
| AfricanAmerican-vs-Asian |
1.253720E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.789900E-02 |
| Normal-vs-Female |
7.206400E-02 |
| Male-vs-Female |
5.130800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.040830E-01 |
| Normal-vs-Age(41-60Yrs) |
9.556100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.786300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.013700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.938000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.808000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.614800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.671200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.141800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.846000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.718600E-01 |
| Classical-VS-Follicular |
4.495200E-01 |
| Classical-VS-Other |
9.847400E-01 |
| Classical-VS-Normal |
9.087600E-02 |
| Tall-VS-Follicular |
8.274800E-01 |
| Tall-VS-Other |
9.570000E-01 |
| Tall-VS-Normal |
2.487000E-01 |
| Follicular-VS-Other |
8.159200E-01 |
| Follicular-VS-Normal |
5.427900E-02 |
| Other-VS-Normal |
5.117000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.250440E-01 |
| Normal-vs-N1 |
5.187900E-04 |
| N0-vs-N1 |
9.979400E-04 |
|
|
